Long-Term Safety of Febuxostat in Subjects With Gout.
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of febuxostat, once daily (QD),
in maintaining serum urate levels within clinically acceptable levels in subjects with gout.